The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Meyer Andrew Hollman since 2024.
This trader's CIK number is 1864159.
At the time of last reporting, Meyer Andrew Hollman was the Chief Business Officer of Janux Therapeutics, Inc.. (stock ticker symbol JANX).
Also see all insider trading activities at Janux Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | JANX | 0 | $0 | 13,335 | $458,254 | 13,335 | $56,139 |
| 2024 | JANX | 0 | $0 | 50,000 | $2,297,750 | 59,881 | $379,761 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-01 | JANX | Option Ex | 3,333 | 4.21 | 14,031 |
| 2025-05-01 | JANX | Sale | 3,333 | 32.28 | 107,575 |
| 2025-04-21 | JANX | Sale | 3,334 | 30.00 | 100,020 |
| 2025-04-21 | JANX | Option Ex | 3,334 | 4.21 | 14,036 |
| 2025-03-03 | JANX | Option Ex | 3,334 | 4.21 | 14,036 |
| 2025-03-03 | JANX | Sale | 3,334 | 32.37 | 107,914 |
| 2025-02-03 | JANX | Sale | 3,334 | 42.81 | 142,745 |
| 2025-02-03 | JANX | Option Ex | 3,334 | 4.21 | 14,036 |
| 2024-12-19 | JANX | Option Ex | 9,881 | 17.13 | 169,261 |
| 2024-09-27 | JANX | Option Ex | 50,000 | 4.21 | 210,500 |
| 2024-09-27 | JANX | Sale | 50,000 | 45.95 | 2,297,750 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Meyer Andrew Hollman (Chief Business Officer of Janux Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.